Trueblood Wealth Management’s First Trust Consumer Staples AlphaDEX Fund FXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$528K Buy
8,429
+9
+0.1% +$565 0.18% 154
2026
Q1
$537K Sell
8,420
-278
-3% -$18.1K 0.21% 144
2025
Q4
$528K Buy
8,698
+44
+0.5% +$2.73K 0.21% 145
2025
Q3
$542K Buy
8,654
+68
+0.8% +$4.35K 0.21% 139
2025
Q2
$543K Sell
8,586
-27
-0.3% -$1.73K 0.23% 132
2025
Q1
$563K Sell
8,613
-1,463
-15% -$93.8K 0.26% 124
2024
Q4
$645K Hold
10,076
0.32% 107
2024
Q3
$688K Sell
10,076
-76
-0.7% -$5.07K 0.35% 95
2024
Q2
$654K Sell
10,152
-3
-0% -$199 0.37% 87
2024
Q1
$696K Sell
10,155
-157
-2% -$10.1K 0.4% 84
2023
Q4
$651K Buy
+10,312
New +$620K 0.41% 79

Other funds holding FXG

Trueblood Wealth Management's FXG Position: Q2 2026 in Review

Trueblood Wealth Management increased its First Trust Consumer Staples AlphaDEX Fund (FXG) stake by 0.11% in Q2 2026, buying an estimated $565 and bringing the position to 8,429 shares worth $528K. The position accounts for 0.18% of the portfolio, ranked #154.

Trueblood Wealth Management first reported a position in FXG in Q4 2023 and has held it in 11 quarters since. The position peaked at $696K in Q1 2024. 108 funds tracked by Wall St. Rank hold FXG as of Q2 2026.

  • Trueblood Wealth Management held 8,429 shares of First Trust Consumer Staples AlphaDEX Fund worth $528K as of Q2 2026.
  • Trueblood Wealth Management bought 9 First Trust Consumer Staples AlphaDEX Fund shares in Q2 2026, an estimated $565.
  • First Trust Consumer Staples AlphaDEX Fund made up 0.18% of Trueblood Wealth Management's portfolio in Q2 2026, its #154 holding.
  • Trueblood Wealth Management first reported a position in First Trust Consumer Staples AlphaDEX Fund in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's First Trust Consumer Staples AlphaDEX Fund position peaked at $696K in Q1 2024.
  • 108 funds tracked by Wall St. Rank held First Trust Consumer Staples AlphaDEX Fund as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.